Clinical Trials Logo

Morality clinical trials

View clinical trials related to Morality.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06398782 Completed - Body Composition Clinical Trials

Prognostic Effect of Body Composition in Cancer Survivors

Start date: January 1, 1999
Phase:
Study type: Observational [Patient Registry]

This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.

NCT ID: NCT06170424 Completed - Morality Clinical Trials

Retrospective Analysis of Spray Skin Treats for Severe Burns

Start date: January 1, 2012
Phase:
Study type: Observational

This study investigated the efficacy of novel approach spray skin for extensive severe burns treatment.

NCT ID: NCT06040606 Completed - Clinical trials for Postoperative Complications

Postoperative Complications and Mortality With In-Hospital COVID-19 Omicron Infection After Surgery

Start date: February 1, 2023
Phase:
Study type: Observational [Patient Registry]

Postoperative complications and mortality in patients with COVID-19 Omicron infection who have undergone specialized thoracic surgery are scarce. Subsequently, the patient cohort was divided into two groups for comparative analysis: Group 1 (G1), which comprised patients who acquired nosocomial omicron infection after surgery, and Group 2 (G2), which comprised patients who remained uninfected with omicron during their hospitalization period. Propensity score matching (PSM) analysis was conducted using the PSMATCH function in SPSS 27 to assess the incidence of perioperative complications and mortality rates between both groups.

NCT ID: NCT05844410 Completed - COVID-19 Pandemic Clinical Trials

Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study

Start date: October 20, 2021
Phase:
Study type: Observational

Despite the recommendations to avoid using corticosteroids systematically for hospitalized coronavirus disease of 2019 (COVID-19) patients, healthcare professionals used personalized treatments, including corticosteroids, as adjuncts to treat their patients due to their limited access to treatment options. This study aims to evaluate the use of corticosteroids among hospitalized COVID-19 patients with all-cause mortality as the primary outcome and to assess the predictors of all-cause mortality associated with the characteristics of the patients and the corticosteroid regimens adopted.

NCT ID: NCT05726565 Completed - Clinical trials for Cognitive Impairment

Impact of Cardiac Rehabilitation on Acute Heart Failure Patients With Cognitive Impairment

Start date: March 1, 2015
Phase:
Study type: Observational

In heart failure patients, neuropsychological disorders have been prospectively linked to frequent hospitalizations, recurrent cardiac events, and mortality. Cognitive dysfunction is also a frequent comorbidity in heart failure (HF) patients. The benefit of cardiac rehabilitation between patients with cognitive dysfunction and patients without cognitive dysfunction is unknown. Investigators hypothesize that patients with cognitive dysfunction benefit more from cardiac rehabilitation programs than patients without cognitive dysfunction.

NCT ID: NCT05724914 Completed - Cardiac Arrest Clinical Trials

Call to Door Timing in Out-of-hospital Cardiac Arrest

Start date: February 14, 2023
Phase:
Study type: Observational

The investigators aimed to investigate the effect of delayed hospitalization on the basis of the call time on the clinical outcomes of patients with OHCA patients using a nationwide OHCA registry.

NCT ID: NCT05549986 Completed - Trauma Clinical Trials

Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

Start date: January 1, 2016
Phase:
Study type: Observational

We evaluated a cohort of adult trauma patients transported to emergency departments. The first vital signs were used to calculate the SI, MSI, and rSIG. The areas under the receiver operating characteristic curves (AUROCs) and test results were used to compare the discriminant performance of the indices on short-term mortality and poor functional outcome. A subgroup analysis of geriatric patients, traumatic brain injury, penetrating injury, and non-penetrating injury was performed.

NCT ID: NCT05527678 Completed - Quality of Life Clinical Trials

5 Years Quality of Life and Early Mobilization in ICU

Promorea-qol
Start date: October 28, 2022
Phase:
Study type: Observational

In a study published in 2018 the research team had collected the Medical Research Council score (MRCs) at Intensive Care Unit (ICU) discharge. The investigators would like to be able to examine, if the preliminary results obtained by in 2020 by Van Aerde's team are confirmed in their cohort. The investigators hypothesize that patients with an MRCs less than or equal to 55 at discharge from the ICU, have a higher mortality rate than those with a score greater than 55. The investigators would also like to examine whether or not an MRCs score ≤ 55 is associated with a difference in quality of life and autonomy, after 5 and more years post ICU.

NCT ID: NCT05487716 Completed - Heart Failure Clinical Trials

HIIT Effects on Long-term Survival in Heart Failure Patients

Start date: January 1, 2009
Phase:
Study type: Observational

The American Heart Association announces that exercise training should be considered for all stable cardiac patients (Class I, Level A). Therefore, exercise is an important issue for cardiac patients. It has also been reported that high-intensity interval training (HIIT) brings benefits on reversal of cardiac remodeling and long-term survival for HF patients. This study explores high-intensity interval training (HIIT) effects on long-term survivals in heart failure (HF) patients, diagnosed according to the Framingham criteria. This retrospective cohort study is going to analyze HF patients diagnosed between January 1, 2009 and May 31, 2022 in a tertiary care hospital. All HF patients underwent the multidisciplinary disease management program (MDP) in the hospital were initially surveyed. Participants were further categorized into HF with reduced ejection fraction (HFrEF) (left ventricle ejection fraction [LVEF]<40%), HF with mildly reduced EF (HFmrEF) (LVEF>=40% and LVEF< 50%), and HF with preserved EF (HFpEF) ( LVEF>=50%) based on the initial 2-D echocardiography. Participants will be further divided into HIIT+MDP or MDP only in each group based on patient preference. Age, sex, body height, body weight, disease duration, etiology for HF, co-morbidities, and medication were documented during follow-up (F/U). B-type natriuretic peptide, natriuretic peptide (BNP), cardiopulmonary exercise test (CPET) for peak oxygen consumption (VO2peak) and 2-D echocardiography for LV geometry were repeatedly assessed during follow-up. The end-point is the death of the patients or the date of May 31, 2022. All mortality causes and overall survival rates will be determined at the end of F/U. HIIT effects on long-term survival (Kaplan-Meier survival curve) for patients with different heart failure phenotypes will be estimated by log rank test. Continuous variables between different groups were analyzed by student t-test, while continuous variables before and after HIIT within groups were assessed by paired t-test. Other non-continuous variables such as sex, and co-morbidities were compared by chi-square test.

NCT ID: NCT05455528 Completed - Renal Insufficiency Clinical Trials

Preoperative Renal Insufficiency Predicts Postoperative Adverse Outcomes

Start date: January 1, 2022
Phase:
Study type: Observational

The main purpose of this study is to evaluate the risk of postoperative mortality and complications in surgical populations with preoperative renal insufficiency.